Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • IR Contact
  • Presentations

Nomination committee

In accordance with the decision at Qlife Holding's Annual General Meeting 2021, the company's Chairman of the Board has convened a Nomination Committee to prepare proposals for the Company's  Annual General Meeting 2022. The Nomination Committee consists of the following persons, who together represent approximately 25 percent of the company's shares and votes.

  • Sören Skärbäk, appointed by Thomas Warthoe,
  • Anita Otterheim Hjalmarsson, appointed by Peter Warthoe,
  • Lars Bangsgaard, representing own shares, and
  • Mette Gross, Chairman of the Board

The Nomination Committee's proposal will be presented in the notice convening the Annual General Meeting 2022 and on the company's website, www.qlifeholding.com.
Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the Nomination Committee at the company's address, Redaregatan 48, 252 36 Helsingborg. In order for the Nomination Committee to be able to consider a proposal, the proposal must have been in due time before the Annual General Meeting, and no later than 7th February 2022.

Instruktion och arbetsordning for valberedningen.pdf

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.